APA (7th ed.) Citation

Mao, W., Shao, M., Gao, P., Ma, J., Li, H., Li, G., . . . Yuan, C. (2012). The important roles of RET, VEGFR2 and the RAF/MEK/ERK pathway in cancer treatment with sorafenib. Acta pharmacologica Sinica, 33(10), 1311-1318. https://doi.org/10.1038/aps.2012.76

Chicago Style (17th ed.) Citation

Mao, Wei-feng, Min-hua Shao, Pin-ting Gao, Ji Ma, Hui-juan Li, Gai-ling Li, Bao-hui Han, and Chong-gang Yuan. "The Important Roles of RET, VEGFR2 and the RAF/MEK/ERK Pathway in Cancer Treatment with Sorafenib." Acta Pharmacologica Sinica 33, no. 10 (2012): 1311-1318. https://doi.org/10.1038/aps.2012.76.

MLA (9th ed.) Citation

Mao, Wei-feng, et al. "The Important Roles of RET, VEGFR2 and the RAF/MEK/ERK Pathway in Cancer Treatment with Sorafenib." Acta Pharmacologica Sinica, vol. 33, no. 10, 2012, pp. 1311-1318, https://doi.org/10.1038/aps.2012.76.